Introduction
Helicobacter pylori establishes long-term chronic infections in the human gastric mucosa that can lead to active chronic gastritis and peptic ulcer disease [1, 2] , and is an early risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma [3, 4] . Metronidazole (Mtz) is frequently included as one component in multidrug treatment regimens. However, the prevalence of Mtz resistance (MtzR) in some populations is very high, and this decreases the overall success rate of Mtz-based eradication regimens [5, 6, 7] .
Two related chromosomal nitroreductase genes, rdxA (HP0954) and frxA (HP0642) in the genome sequence, have been implicated in susceptibility and resistance to Mtz of H. pylori strains from diverse parts of the world, including East Asia [8, 9, 10, 11] . The nitroreductase enzymes these genes encode can activate Mtz by converting it from a harmless prodrug to a mutagenic and bactericidal agent (probably hydroxylamine).
Most MtzR clinical isolates contain loss of function mutations in rdxA, and inactivation of rdxA in MtzS strains is generally sufficient to make them resistant to moderate levels of Mtz (16 micrograms/ml, up from 1.5 micrograms per ml, when measured as in the present experiments). Resistance to higher levels of Mtz is common in clinical isolates (typically some half of those that are MtzR), and can be achieved by inactivation of frxA (an rdxA homolog, located elsewhere in the chromosome). In our hands, this depends on the strain already being mutant in rdxA [9] . Another group has suggested that frxA inactivation by itself might be sufficient to render a MtzS strain MtzR [10] . Studies demonstrating that Mtz activation is mutagenic [12] had suggested that yet other cellular nitroreductases might also activate Mtz when present in high concentration, but the full hierarchy of nitroreductases that can contribute to Mtz toxicity to H. pylori has not been elucidated.
H. pylori is an extremely diverse species, and independent clinical isolates can usually be distinguished by any of several DNA fingerprinting methods, including the random amplified polymorphic DNA (RAPD) method used here [13] . Differences in DNA patterns of isolates from a particular patient indicate presence of more than one strain. However, studies of the frequency of mixed infections has given seemingly conflicting results, with some indicating that most infected persons harbor only one H. pylori strain [13, 14, 15] , and others indicating frequent mixed infection by more than one strain [16, 17, 18] .
Antimicrobial susceptibility testing has usually been applied to pools of colonies from a primary culture of gastric antrum alone. It has been noted however, that H. pylori isolates with identical RAPD patterns may show different patterns of Mtz susceptibility [17, 19, 20] , although studies of the MtzR fractions from mixed but predominantly MtzS infections can sometimes identify strains of other genotype. Other anecdotal evidence has suggested that different strains can sometimes predominate in different sites. Most analyses of H. pylori in infected individuals have been carried out using US or European residents, but there is emerging evidence that different H. pylori genotypes predominate in different human populations [21] , and that the spectrum of gastroduodenal diseases that H. pylori causes also differs regionally [22] . Therefore, the aims of this study were to investigate the prevalence of multiple strain infection in a symptomatic Chinese population and to determine the metronidazole susceptibility pattern and genotype variation of these infecting strains.
Materials and Methods

Subjects and Specimens
From November 1998 to June 1999, subjects presenting with upper abdominal symptoms referred for upper endoscopy to the Endoscopy Unit, Department of Medicine, Queen Mary Hospital and who fulfilled the inclusion and exclusion criteria were enrolled prospectively into the study. Subjects giving informed consent were included if they were between age 18 to 85 years old, and with no previous history of H. pylori eradication and no evidence of active bleeding on endoscopic examination. They were excluded if they have taken antibiotics, proton pump inhibitors, bismuth-containing compounds, or H 2 -receptor antagonists within the recent four weeks; had a history of gastrectomy, or had severe concomitant medical illness.
Forty six H. pylori positive subjects were included in this study. There were 27 males and 19 females, with a mean age of 56 years, ranging from 22 to 85 years. All patients were ethnic Chinese residents of Hong Kong. No data on prior metronidazole exposure of these specific patients was available. However, typically such patients may have had about two to three courses of metronidazole therapy (for other ailments) during the preceding ten to twenty years.
Three gastric biopsies were taken for bacterial culture, one each from the antrum, body and cardia of the stomach of each patient. Each biopsy was taken from similar sites of antrum (2cm from the pylorus), body (greater curvature, midway between pylorus and oesophageo-gastric junction) and cardia (greater curvature, 4cm from the OG junction) of the stomach. Further biopsies were taken for rapid urease test and histology examination, after the biopsies for culture have been taken. All endoscopies were performed by a single endoscopist (BCYW) to ensure accurate collection of specimens from different sites of the stomach. Each biopsy specimen for culture was placed in a tube containing 0.5 ml of brain heart infusion (BHI, Oxoid, Basingstoke, UK) medium with 20% glycerol and immediately frozen at -70 0 C until further use.
Single and Multiple colony Strains Isolation
Each biopsy specimen was cultured on selective media (Columbia agar with 7% 
Determination of Mtz Susceptibility and Selection of Mtz Resistant Isolates
All H. pylori cultures derived from single, and also from multiple colonies (pools of over five colonies) were tested for susceptibility to Mtz. Briefly, H. pylori cultures were suspended in BHI broth and adjusted to a McFarland turbidity of 1 (3x10 8 cfu/ml).
Ten μl aliquots of each suspension were then spread and plated on medium containing 8 μg/ml Mtz and on control medium that was free of Mtz. Growth on Mtz containing medium indicated resistance. Resistant colonies from pools were re-plated again on the same medium and re-grown to obtain pure MtzR cultures.
Preparation of Genomic DNA
For each patient and each biopsy site, H. pylori genomic DNA was prepared from unselected single colony isolates, and also from pools of more than ten colonies and from Mtz-selected isolates if available. Bacteria were grown to confluency, harvested with sterile cotton swab applicators, and washed once by centrifugation with TE buffer (10mM Tris-HCl, 1mM EDTA, pH 8.0). Genomic DNA was prepared using the QIAamp Tissue Kit (Qiagen GmbH, Germany). The DNA concentration was determined spectrophotometrically at 260 nm.
RAPD Fingerprinting
RAPD (or arbitrarily primed PCR) DNA fingerprinting was used to detect DNA sequence diversity among H. pylori isolates [7] . Two arbitrary primers used in this study A positive (known sample of H. pylori DNA) and a negative control were included in each set of PCRs. When different RAPD profiles were obtained from isolates of a particular patient, the RAPD fingerprinting was repeated again, using fresh DNA preparations, to ensure that the differences were real.
Results
Endoscopic diagnosis showed gastritis in 16 patients (35%), duodenal ulcer in 15 patients (33%), gastric ulcer in 12 patients (26%), and gastric cancer in three patients (7%). All cancers were proven histologically.
Bacterial culture H. pylori was successfully cultured from all three gastric sites (antrum, body and cardia) in 32 of 46 patients, from two of the three sites in ten subjects, and from one of the three sites in four subjects. All these 120 sets of cultures (41 from antrum, 42 from body, 37 from cardia) were also represented by two to five related single colony isolates per biopsy site, giving a total of 418 isolates. All isolates were tested for susceptibility to Mtz.
Metronidazole resistance
Subjects were classified into three groups based on metronidazole susceptibility patterns from both pools and single colony isolates. pylori than those with MtzR strains (p<0.001). However, there was no significant difference in the eradication rate of MtzR strains by using regimes with or without metronidazole, but the numbers in each subgroup were small.
RAPD Fingerprinting of H. pylori
The genetic diversity of H. pylori strains in a given patient was assessed by RAPD fingerprinting using 298 single colony isolates obtained from different gastric sites, 120 pooled cultures and 43 MtzR isolates, when present. Two different primers were used in separate reactions to give better sensitivity.
Uniform RAPD fingerprint patterns were found in comparisons of single colony More than one RAPD pattern was observed in 31%, 27%, 17% of non-ulcer dyspepsia, duodenal ulcer and gastric ulcer patients, respectively. The isolates from the three gastric cancer patients were uniform in RAPD pattern in each case. Had we only compared the RAPD fingerprint patterns from pools from different biopsy sites (antrum, body and cardia) using a single RAPD primer, then the detected prevalence of mixed infections would have been reduced to 6.5% (3/46). Our definition of MtzR is the ability to grow in the presence of eight micrograms per ml of Mtz. This was chosen for the present large scale tests based on long established criteria [9] , and indications from our own recent studies that most (but not all) clinical isolates resistant to 8 μg/ml (using testing protocol presented here) are resistant to 16 μg/ml, and that about half of them are resistant to 32 μg/ml [9] . We found that resistance to only 8 μg/ml is attributable to leaky mutations in rdxA. Resistance to 16 μg/ml but not 32 μg/ml reflects null mutations in rdxA, and resistance to 32 μg/ml reflects null mutations in rdxA and frxA [9 and, J. Y. Jeong, and D. E. Berg, unpublished results].
Correlation between Metronidazole susceptibility pattern and RAPD fingerprinting
Megraud et al had suggested that only resistance to at least 32 μg/ml predicted failure of
Mtz-based eradication therapy [23] . The observation that 71% of patients in our study who were infected with MtzR strains had successful eradication of the infection may suggest that the threshold for metronidazole resistance in our study might be set too low.
The high prevalence of MtzR and MtzS/R mixed infection has been important
clinically: all patients that seemed to be infected only by MtzS strains were successfully treated. The 30% treatment failures occurred only in patients that had been colonized with at least some MtzR H. pylori. In this context, it was also remarkable that some MtzR This might reflect sometimes achieving higher effective concentrations of Mtz in the gastric mucosa than even "resistant" strains can tolerate.
There was a discrepancy in results of some MtzR tests using single colonies and pools: four patients judged from tests using pools to have purely MtzS infections yielded at least one single colony isolate with a bona fide MtzR phenotype. Similarly discrepant results have also been reported by others [26] . Some of these cases might reflect chance, stemming from our having tested different colonies individually and in pools, and the relatively few colonies available for pooling from some of our biopsies. Perhaps also affecting this might be the apparently lower "fitness" of many MtzR H. Several earlier studies have reported that individuals can be infected by strains of more than one genotype, with the fraction of persons found to carry multiple strains ranging from 0 to 85% (mean 20%) [14, 15, 17, 18, 19, [27] [28] [29] [30] [31] [32] [33] . Some of the strains we recovered from mixed infections (24% of infections analyzed) were in a small minority, and were found only because numerous single colonies or Mtz-selected colonies were analyzed. The differences in apparent prevalence of such mixed infections in different reports can be attributed to a combination of factors, including sampling strategy used:
from one vs. several gastric sites, and the sites of biopsy (all antrum, vs. antrum, body and cardia); tests of pools vs. single colonies from each biopsy; analysis of drug resistant fractions as well as unselected strains, to increase chance of detecting minority subpopulations; and the sensitivity of the strain typing method used. In any case, it is now clear that tests of Mtz susceptibility using only H. pylori from antral sites, as had been quite typical of studies in the past, may often not fully sample the entire H. pylori population throughout the stomach. We suggest that several different sites need to be analyzed, at least including both the antrum and the corpus.
We might expect the actual chance of finding mixed infections to also reflect the overall risk of infection in the society under study. However, a clinical trial in Guangzhou, China (where the overall risk of H. pylori infection should be more than in Hong Kong), had indicated that new adult infections are uncommon [34] . If this finding is applicable to the present Hong Kong Chinese population, it is attractive to imagine that the mixed infections by different genotypes found here may represent a long-term stable association, one that has persisted for years. Whether this indicates specialization of certain strains for just a subset of gastric mucosal niches remains to be determined.
In conclusion, our study has shown that mixed MtzS/R infections are common in Hong Kong, and that genotypes are not uniformly distributed throughout the gastric mucosa. This makes it prudent to study strains from several biopsy sites when testing for traits such as drug resistance or virulence in relation to disease. Infections that were mixed in terms of overall genotype were found in 24% of patients, and this did not correlate with the 43.5 % of infections that were mixed with regard to Mtz susceptibility.
Further studies are needed to address issues such as the effects of MtzR on virulence, the importance of Mtz-induced mutation in bacterial adaptation and evolution during chronic infection, competition among strains during mixed infection vs. the possibility of specialization of certain H. pylori strains for particular gastric sites. demonstrated two different RAPD patterns, which were confirmed by using 2 ng and 10 ng templete concentrations, and by using primers 1281 and 1254.
